» Articles » PMID: 15720435

Natural Killer T-cell Populations in C57BL/6 and NK1.1 Congenic BALB.NK Mice-a Novel Thymic Subset Defined in BALB.NK Mice

Overview
Journal Immunology
Date 2005 Feb 22
PMID 15720435
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) T lymphocytes are a subpopulation of T lymphocytes regarded as early regulators of immune responses. The majority of NKT cells are restricted by the CD1d molecule. NKT cells have mostly been studied in one single mouse strain, C57BL/6 (B6), because of the absence of NK1.1 in other common mouse strains, and the lack of other reliable surface markers for CD1d-restricted cells. To investigate NKT cell subsets in a mouse strain of a genetic background different from B6, we have back-crossed the NKT cell marker NK1.1 from the B6 mouse to the BALB/c mouse strain. We show that NKT cells in the congenic BALB.B6-NK1.1(b) mouse share many characteristics with their B6 counterparts, but seem to be deficient in the functional NKT cell subtype characterized by low interleukin-4 and high interferon-gamma production, and surface expression of CD49b but not CD69. Moreover, in the thymus but not the spleen of BALB.B6-NK1.1(b) mice we find a novel Valpha14-Jalpha18 invariant NKT cell subset which is devoid of a set of NK markers, suggesting that these cells represent a less differentiated NKT cell stage, and carries high levels of the T-cell receptor and uses a skewed T-cell receptor Vbeta-repertoire.

Citing Articles

invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.


Glycolipid-peptide conjugate vaccines elicit CD8 T-cell responses and prevent breast cancer metastasis.

Burn O, Farrand K, Pritchard T, Draper S, Tang C, Mooney A Clin Transl Immunology. 2022; 11(7):e1401.

PMID: 35795321 PMC: 9250805. DOI: 10.1002/cti2.1401.


Natural Killer Cells Are Present in Rag1 Mice and Promote Tissue Damage During the Acute Phase of Ischemic Stroke.

Rolfes L, Ruck T, David C, Mencl S, Bock S, Schmidt M Transl Stroke Res. 2021; 13(1):197-211.

PMID: 34105078 PMC: 8766401. DOI: 10.1007/s12975-021-00923-3.


Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.

Singh A, Rhost S, Lofbom L, Cardell S Scand J Immunol. 2019; 90(3):e12794.

PMID: 31141185 PMC: 6851763. DOI: 10.1111/sji.12794.


Immature murine NKT cells pass through a stage of developmentally programmed innate IL-4 secretion.

Dickgreber N, Farrand K, van Panhuys N, Knight D, McKee S, Chong M J Leukoc Biol. 2012; 92(5):999-1009.

PMID: 22941735 PMC: 4050521. DOI: 10.1189/jlb.0512242.


References
1.
Porcelli S, Modlin R . The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol. 1999; 17:297-329. DOI: 10.1146/annurev.immunol.17.1.297. View

2.
Yagi J, Dianzani U, Kato H, Okamoto T, Katsurada T, Buonfiglio D . Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen. J Immunol. 1999; 163(6):3083-91. View

3.
Coles M, McMahon C, Takizawa H, Raulet D . Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol. 1999; 30(1):236-44. DOI: 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO;2-X. View

4.
Gumperz J, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T . Murine CD1d-restricted T cell recognition of cellular lipids. Immunity. 2000; 12(2):211-21. DOI: 10.1016/s1074-7613(00)80174-0. View

5.
Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A . In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med. 2000; 191(11):1895-903. PMC: 2213523. DOI: 10.1084/jem.191.11.1895. View